金黄色葡萄球菌菌血症临床试验的异质性使结果解读复杂化
本文系统评价了金黄色葡萄球菌菌血症(SAB)的随机对照试验(RCT)。发现试验间在队列特征(菌血症来源、复杂性SAB、合并症)上存在异质性,队列特征报告本身也不一致,选择偏倚由合并症、疾病严重程度、感染类型和感染源控制的排除标准引入。RCT对照组死亡率低于观察性队列,结局定义差异阻碍荟萃分析。
要点
- SAB随机对照试验间在菌血症来源、复杂性SAB和合并症等队列特征上存在异质性。
- 排除标准涉及合并症、疾病严重程度、感染类型和感染源控制,引入了选择偏倚。
- RCT对照组死亡率低于观察性队列,结局定义差异阻碍荟萃分析。
核心结论
- SAB随机对照试验间的异质性使结果解读和应用复杂化。
- 应通过标准化的招募、定义和报告方法最大化这些试验的价值。
研究设计与样本
- 系统评价金黄色葡萄球菌菌血症的随机对照试验(RCT)。
主要发现
- 试验间在队列特征上存在异质性,包括菌血症来源、复杂性SAB和合并症。
- 队列特征报告本身不一致,包括菌血症来源和疾病严重程度。
- 选择偏倚由涉及合并症、疾病严重程度、感染类型和感染源控制的排除标准引入。
- RCT对照组死亡率低于观察性队列。
- 结局定义的差异阻碍荟萃分析。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We systematically evaluated randomized-controlled trials (RCTs) for Staphylococcus aureus bacteremia (SAB). There was intertrial heterogeneity in cohort characteristics, including bacteremia source, complicated SAB, and comorbidities. Reporting of cohort characteristics was itself variable, including bacteremia source and illness severity. Selection bias was introduced by exclusion criteria relating to comorbidities, illness severity, infection types, and source control. Mortality was lower in RCT control arms compared with observational cohorts. Differences in outcome definitions impedes meta-analysis. These issues complicate the interpretation and application of SAB RCT results. The value of these trials should be maximized by a standardized approach to recruitment, definitions, and reporting.
引用
- Dolby HW, Clifford SA, Laurenson IF, et al. Heterogeneity in Staphylococcus aureus Bacteraemia Clinical Trials Complicates Interpretation of Findings. J Infect Dis. 2022. PMID: 35639909. doi:10.1093/infdis/jiac219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。